German Pharmaceuticals & Biotech Potentially Undervalued Companies

Hisamitsu Pharmaceutical

Market Cap: €297.7b

Manufactures and sells pharmaceuticals in Japan.

Dermapharm Holding

Market Cap: €1.8b

Manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.

Ono Pharmaceutical

Market Cap: €803.3b

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

IQVIA Holdings

Market Cap: €31.8b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Verrica Pharmaceuticals

Market Cap: €41.7m

A dermatology therapeutics company, engages in the development and sale of medications for the treatment of skin diseases in the United States.

MPH Health Care

Market Cap: €79.8m

An investment company, engages in the healthcare business in Germany.

Auxly Cannabis Group

Market Cap: €182.0m

Operates as a consumer packaged goods company in the cannabis products market in Canada.

Cellectis

Market Cap: €195.6m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.

Lee's Pharmaceutical Holdings

Market Cap: €1.5b

An investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally.

Esperion Therapeutics

Market Cap: €548.4m

A pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States.

Animalcare Group

Market Cap: €172.5m

Develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets.

Legend Biotech

Market Cap: €6.4b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Enanta Pharmaceuticals

Market Cap: €161.2m

A biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases.

Photocure

Market Cap: €1.6b

Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.

Relmada Therapeutics

Market Cap: €7.7m

Operates as a clinical-stage biotechnology company in the United States.

Planet 13 Holdings

Market Cap: €87.8m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

Mayne Pharma Group

Market Cap: €305.4m

A specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.

Hypera

Market Cap: €14.8b

Operates as a pharmaceutical company in Brazil.

Exelixis

Market Cap: €10.5b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Royalty Pharma

Market Cap: €20.7b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Enlivex Therapeutics

Market Cap: €25.8m

Operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel.

Hypera

Market Cap: €14.6b

Operates as a pharmaceutical company in Brazil.

Thermo Fisher Scientific

Market Cap: €181.5b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

Dermapharm Holding

Market Cap: €1.8b

Manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.

Vetoquinol

Market Cap: €936.6m

A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.

Eurofins Scientific

Market Cap: €11.1b

Provides various analytical testing and laboratory services worldwide.

Santen Pharmaceutical

Market Cap: €535.8b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Revolution Medicines

Market Cap: €8.4b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Theratechnologies

Market Cap: €208.3m

A biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe.

aTyr Pharma

Market Cap: €105.8m

A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.

GSK

Market Cap: €59.3b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Tecan Group

Market Cap: €2.0b

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.

Qiagen

Market Cap: €9.9b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Beximco Pharmaceuticals

Market Cap: €54.5b

Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.

PharmaSGP Holding

Market Cap: €340.8m

Manufactures and sells over-the-counter drugs and other healthcare products in Germany.

Towa Pharmaceutical

Market Cap: €143.7b

Manufactures and sale ethical drugs in Japan.